Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/42685
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDe Los Santos Gil, I.-
dc.contributor.authorUstianowski, A.-
dc.contributor.authorOrofino, G.-
dc.contributor.authorScholten, S.-
dc.contributor.authorMESSIAEN, Peter-
dc.contributor.authorMaggiolo, F.-
dc.contributor.authorBraun, D.-
dc.contributor.authorWyen, C.-
dc.contributor.authorDemeester, R.-
dc.contributor.authorJacomet, C.-
dc.contributor.authorCua, E.-
dc.contributor.authorCalmy, A.-
dc.contributor.authorClarke, E.-
dc.contributor.authorSarcletti, M.-
dc.contributor.authorDakhia, S.-
dc.contributor.authorSutton, K.-
dc.contributor.authorSutherland-Phillips, D.-
dc.contributor.authorLatham, C. L.-
dc.contributor.authorBerni, A.-
dc.contributor.authorUrbaityte, R.-
dc.contributor.authorPascual-Bernaldez, M.-
dc.contributor.authorNgenzi, B.-
dc.contributor.authorSchroeder, M.-
dc.contributor.authorVan Solingen-Ristea, R.-
dc.contributor.authorBaugh, B.-
dc.contributor.authorD'Amico, R.-
dc.contributor.authorVan Wyk, J.-
dc.date.accessioned2024-03-26T10:38:09Z-
dc.date.available2024-03-26T10:38:09Z-
dc.date.issued2023-
dc.date.submitted2024-03-26T09:49:26Z-
dc.identifier.citationHIV MEDICINE, 24 , p. 204 -206-
dc.identifier.urihttp://hdl.handle.net/1942/42685-
dc.language.isoen-
dc.publisherWILEY-
dc.titleSOLAR 12-month European results: Randomized switch trial of CAB plus RPV vs. oral BIC/FTC/TAF-
dc.typeJournal Contribution-
dc.identifier.epage206-
dc.identifier.spage204-
dc.identifier.volume24-
local.format.pages3-
local.bibliographicCitation.jcatM-
local.publisher.place111 RIVER ST, HOBOKEN 07030-5774, NJ USA-
local.type.refereedRefereed-
local.type.specifiedMeeting Abstract-
dc.identifier.isi001174349600197-
local.provider.typewosris-
local.description.affiliation[De Los Santos Gil, I.] Hosp Princesa, Inst Salud Carlos III, Internal Med & Infect Dis Dept, CIBERINFEC, Madrid, Spain.-
local.description.affiliation[Ustianowski, A.] Manchester Univ NHS Fdn Trust, Manchester, Lancs, England.-
local.description.affiliation[Orofino, G.] Amedeo di Savoia Hosp, Div A, Unit Infect Dis, Turin, Italy.-
local.description.affiliation[Scholten, S.] Praxis Hohenstaufenring, Cologne, Germany.-
local.description.affiliation[Messiaen, P.] Jessa Hosp, Dept Infect Dis & Immun, Hasselt, Belgium.-
local.description.affiliation[Messiaen, P.] Hasselt Univ, Fac Med & Life Sci, Hasselt, Belgium.-
local.description.affiliation[Maggiolo, F.] ASST Papa Giovanni XXIII, UOC Infect Dis, Bergamo, Italy.-
local.description.affiliation[Braun, D.] Univ Hosp Zurich, Dept Infect Dis & Hosp Epidemiol, Zurich, Switzerland.-
local.description.affiliation[Braun, D.] Univ Hosp Zurich, Inst Med Virol, Zurich, Switzerland.-
local.description.affiliation[Wyen, C.] Praxis Ebertpl, Cologne, Germany.-
local.description.affiliation[Demeester, R.] Univ Hosp Charleroi, Charleroi, Belgium.-
local.description.affiliation[Jacomet, C.] CHU Clermont Ferrand, Infect Dis Unit, Clermont Ferrand, France.-
local.description.affiliation[Cua, E.] Hop LArchet, Nice, France.-
local.description.affiliation[Calmy, A.] Geneva Univ Hosp, Div Infect Dis, HIV AIDS Unit, Geneva, Switzerland.-
local.description.affiliation[Clarke, E.] Liverpool Univ Hosp NHS Fdn Trust, Royal Liverpool Univ Hosp, Liverpool, Merseyside, England.-
local.description.affiliation[Sarcletti, M.] Med Univ Innsbruck, HIV Unit, Dept Dermatol Venereol & Allergol, Innsbruck, Austria.-
local.description.affiliation[Dakhia, S.; Schroeder, M.; Van Wyk, J.] ViiV Healthcare, Brentford, England.-
local.description.affiliation[Sutton, K.; Sutherland-Phillips, D.; Latham, C. L.; D'Amico, R.] ViiV Healthcare, Durham, NC USA.-
local.description.affiliation[Berni, A.; Urbaityte, R.] GSK, Brentford, England.-
local.description.affiliation[Pascual-Bernaldez, M.] ViiV Healthcare, Madrid, Spain.-
local.description.affiliation[Ngenzi, B.] ViiV Healthcare, Wavre, Belgium.-
local.description.affiliation[Van Solingen-Ristea, R.] Janssen Res & Dev, Beerse, Belgium.-
local.description.affiliation[Baugh, B.] Janssen Res & Dev, Raritan, NJ USA.-
local.uhasselt.internationalyes-
item.fullcitationDe Los Santos Gil, I.; Ustianowski, A.; Orofino, G.; Scholten, S.; MESSIAEN, Peter; Maggiolo, F.; Braun, D.; Wyen, C.; Demeester, R.; Jacomet, C.; Cua, E.; Calmy, A.; Clarke, E.; Sarcletti, M.; Dakhia, S.; Sutton, K.; Sutherland-Phillips, D.; Latham, C. L.; Berni, A.; Urbaityte, R.; Pascual-Bernaldez, M.; Ngenzi, B.; Schroeder, M.; Van Solingen-Ristea, R.; Baugh, B.; D'Amico, R. & Van Wyk, J. (2023) SOLAR 12-month European results: Randomized switch trial of CAB plus RPV vs. oral BIC/FTC/TAF. In: HIV MEDICINE, 24 , p. 204 -206.-
item.contributorDe Los Santos Gil, I.-
item.contributorUstianowski, A.-
item.contributorOrofino, G.-
item.contributorScholten, S.-
item.contributorMESSIAEN, Peter-
item.contributorMaggiolo, F.-
item.contributorBraun, D.-
item.contributorWyen, C.-
item.contributorDemeester, R.-
item.contributorJacomet, C.-
item.contributorCua, E.-
item.contributorCalmy, A.-
item.contributorClarke, E.-
item.contributorSarcletti, M.-
item.contributorDakhia, S.-
item.contributorSutton, K.-
item.contributorSutherland-Phillips, D.-
item.contributorLatham, C. L.-
item.contributorBerni, A.-
item.contributorUrbaityte, R.-
item.contributorPascual-Bernaldez, M.-
item.contributorNgenzi, B.-
item.contributorSchroeder, M.-
item.contributorVan Solingen-Ristea, R.-
item.contributorBaugh, B.-
item.contributorD'Amico, R.-
item.contributorVan Wyk, J.-
item.fulltextWith Fulltext-
item.accessRightsRestricted Access-
crisitem.journal.issn1464-2662-
crisitem.journal.eissn1468-1293-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
xx.pdf
  Restricted Access		Published version5.02 MBAdobe PDFView/Open    Request a copy
Show simple item record

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.